BS, 1968 – Butler University, Indianapolis, IN MS, 1971 – Indiana University, Indianapolis, IN MD, 1972 – Indiana University, Indiana, IN PhD, 1976 – Indiana University, Indiana, IN
Use of cytochrome P-450 isoenzyme patterns to predict individual toxicity risk for drugs and chemicals that undergo metabolic activation.
Sedation and analgesia.
Use of anti-oxidant/NMDA antagonist therapies to decrease anoxic brain injury.
Use of urinary thioether excretion as an index of exposure to environmental chemicals.
Use of gastrointestinal dialysis to enhance removal of environmental/occupational chemicals from deep compartment body storage sites.
Application of stochastic control theory Bayesian population pharmacokinetics to improve individual patient therapeutics.
Snodgrass WR: Valproic acid medical toxicology. IN:
Brent J et al: Critical Care Toxicology. Diagnosis and Management of
the Critically Poisoned Patient. Elsevier Mosby, Philadelphia PA,
Klein, G. and Snodgrass, W.R. (2000) Food toxins
and poisons from microorganisms. The Cambridge World History of Food,
vol II, Kiple K.F. and Ornelas, K.C. (eds) Cambridge University Press,
Snodgrass, W.R. (1996) Clinical
Toxicology. Casarett and Doull's Toxicology: The Basic Science of
Poisons, 5th ed, Klaassen CD, ed, McGraw-Hill, NY. 969-986.
Use of herbal products in children: risks and unproven benefits. IN:
Neonatal and Pediatric Pharmacology. Therapeutic Principles in Practice.
Lippincott Williams & Wilkins, Philadelphia PA, 2005:841—847
Albers, J.W., Cole P., Greenberg, R.S., Mendel J.S., Monson, R.R., Ross, J.H., Snodgrass, W.R.,
Spurgeon, A., and van Gemert, M. (1999) Analysis of chlorpyrifos
exposure and human health: expert panel report. J. Toxicol Environ